Editor's Note: Green and red arrows refer to intraday stock price movement.

NEW YORK (

TheStreet

) --

CHANGE IN RATINGS

Bristol-Myers

(BMY) - Get Report

was upgraded at Morgan Stanley from Equal-weight to Overweight. $34 price target. Apixaban is performing well, highlighting the company's solid pipeline.

Cavium

(CAVM)

upgraded at UBS from Neutral to Buy. $47.50 price target. Secular growth is likely to enter a new phase.

CME Group

(CME) - Get Report

rated new Outperform at BMO Capital. $340 price target. Company has strong earnings potential and trades at a reasonable valuation.

CSX

(CSX) - Get Report

downgraded at Sterne from Buy to Neutral. Valuation call, based on a $26 price target.

Dollar General

(DG) - Get Report

downgraded at Morgan Stanley from Overweight to Equal-weight. Company is facing margin pressure.

FedEx

(FDX) - Get Report

upgraded at Argus from Hold to Buy. $111 price target. Freight division is performing better.

F5 Networks

( FFIX) downgraded at JPMorgan from Overweight to Neutral. $105 price target. Signs of revenue stabilization.

First Solar

(FSLR) - Get Report

rated new Sell at Maxim. $85 price target. Long-term earnings power is threatened by lower polysilicon prices.

Intercontinental Exchange

(ICE) - Get Report

rated new Market Perform at BMO. $135 price target. Stock is already pricing in the company's growth potential.

Krafton Performance

(KRA) - Get Report

rated new Neutral at Goldman. $43 price target. Attractive revenue growth with a strong competitive position.

MicroStrategy

(MSTR) - Get Report

rated new Buy at UBS. $190 price target. Company sells best of breed business intelligence platforms.

Nabors Industries

(NBR) - Get Report

downgraded at Weeden from Buy to Hold. $28 price target. Stock lacks near-term catalysts.

Nasdaq OMX

I:IXIC

rated new Market Perform at BMO Capital. Valuation call, based on a $28 price target.

Nalco

( NLC) downgraded at Goldman from Neutral to Sell. $28 price target. Company faces rising petrochemical costs.

NYSE Euronext

(NYX)

rated new Outperform at BMO. DBI merger should help create value. $44 price target.

Portland General

(POR) - Get Report

downgraded at JPMorgan from Overweight to Neutral. $27 price target. Near term catalysts have played out.

Transocean

(RIG) - Get Report

downgraded at Weeden from Hold to Buy. $75 price target. Stock has underperformed its peers and the floater market should improve.

End of report.

This article was written by a staff member of TheStreet.